Search
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Alcohol and illicit drug use among young people living with HIV compared to their uninfected peers from the Kenyan coast: prevalence and risk indicators
There is a scarcity of research on drug use patterns among HIV-positive young individuals in Sub-Saharan Africa (YLWH). To fill the gap, the following was set out:
- compare the prevalence of substance use, specifically alcohol and illicit...
Strategies Adopted by Addiction Facilities during the Coronavirus Pandemic to Support Treatment for Individuals in Recovery or Struggling with a Substance Use Disorder: A Scoping Review
This review aimed to identify and synthesize strategies and actions adopted by addiction facilities to support and maintain treatment during the coronavirus disease 2019 (COVID-19) pandemic.
National Drug and Alcohol Facts Week®
National Drug & Alcohol Facts Week® will be held March 21-27, 2022.
Registration opens on November 1, 2021.
Join NIDA for NDAFW and help share facts about drugs, alcohol, and addiction in your community. Sign up for the latest news...
LxAddictions22: Global addictions
Lisbon Addictions is a multidisciplinary conference that provides a forum for networking across addictions.
Submission of abstracts
Potential contributors are invited to submit abstracts for the following main areas/thematic tracks:
- Gl...
Two new tobacco cessation medicines added to the WHO essential medicines list
Every two years, the World Health Organization (WHO) publishes its Model List of Essential Medicines (EML), a collection of medicines considered essential by WHO experts.
The purpose of the list is to guide national authorities on the type...
Challenges in prevention and treatment in the post-pandemic (Argentina-Chile-Mexico-Peru)
ISSUP Argentina presented a webinar that addressed the increased impact of isolation and social distancing stemming from the pandemic on the quality of life of vulnerable populations in Latin America, including children and adolescents...
National Trauma and Substance Use: Lessons learned from the Lebanese Crisis
ISSUP Lebanon are pleased to present their Webinar on National Trauma and Substance Use: Lessons learned from the Lebanese Crisis.
The Relationship between Trauma and Addiction
ISSUP Kenya are pleased to present their Webinar on the cyclic relationship between trauma and addiction and the implication in treatment.
Guide to Indispensable Criteria for Starting-up and Operating Treatment Centers for People with Psychoactive Substance Use Disorders
The WHO Expert Committee on Drug Dependence defines treatment as the process that begins when psychoactive substance users contact a health provider or other community service and may continue through a succession of specific interventions...
Academic Session "The discount of the subjective value of the reinforcer with people who consume psychoactive substances"
Speaker: Dr. Silvia Morales Chainé
Academic session held on Monday, November 8, 2021.
The slides used by Dr. Morales Chainé are available at ISSUP: https://www.issup.net/node/15736
For more publications, presentations, videos...
Synthetic drugs and new psychoactive substances in Latin America and the Caribbean- 2021
The report provides a regional analysis of the key trends and emerging developments of the synthetic drugs and NPS market as well as options for response in Latin America and the Caribbean.
Over the past years, the synthetics drug market...
A Conversation About Corruption in Substance Use Disorder Treatment
Elizabeth Saenz, UNODC, presents on the issue of patient abuse and corruption in treatment and provides a call to action on the need to address this problem that spans across countries.
Lifelong consequences of prenatal drug exposure
This webinar explored the issues of infants withdrawing from maternal drugs of addiction, and problems beyond the newborn period.
Newborn drug withdrawal is often attributed to maternal opioids, but many other drugs can cause serious...
Smoking and drinking- Selected articles from the journal of alcohol and alcoholism
The featured articles investigate the association of smoking products and alcohol consumption, identify causes and influences, and explore therapeutic avenues and cessation interventions.
Free to access until 31 January!
Articles
- Tar...
Considerations for Virtual Services and Supports for Substance Use and Concurrent Disorders [Policy Brief]
The Canadian Centre for Substance Use and Addiction (CCSA) in partnership with the Royal Ottawa Mental Health Centre, the Canadian Psychological Association and Canada Health Infoway, collected national data on the experience and...
Study: Combined treatments are the most effective to stop smoking
This is a study, led by the University of Bristol, and published in Addiction Journal. It was funded by the National Institute for Health Research (NIHR), the research partner of the NHS, public health and social care.
The most effective...
Addiction treatment in India: Legal, ethical and professional concerns reported in the media
This study is a content analysis of newspaper reports from January 1, 2016 to December 31, 2019 looking into legal, ethical and professional concerns regarding the treatment of substance use disorders in India.
2021 NDARC Annual Research Symposium Recordings
The National Drug and Alcohol Research Centre (NDARC) held the 2021 Annual Research Symposium on the 20 - 22 October 2021.
Here you can see recordings of all of the sessions from the three days.
Session One
Topic: Emerging pharmaceutical...
NIDA Frontiers in Addiction Research Mini-Convention
Mark your calendars for the annual Frontiers in Addiction Research Mini-Convention, November 1-2, 2021. Open to the public, the event provides a forum for the latest topics in neuroscience and addiction research. Register online: loom.ly...
